483 Nesher Pharmaceuticals (USA) Jan 2004

483 Nesher Pharmaceuticals (USA) Jan 2004

Erika Butler FDA, Karen Daugherty FDA, Patrick Wisor FDA$119.00 - Available Now

FDA investigators audited the Nesher Pharmaceuticals (USA) - Saint Louis, MO, United States facility and issued inspectional observations (via FDA 483) on 23 Jan 2004.

Product details

  • Category: Human Drugs
  • Inspection end: 23 Jan 2004
  • Location: Saint Louis, United States
  • FEI: 1937079
Add To Cart